Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP1 | P29466 | 13/20 | 0.58 |
| ▸ | CASP5 | P51878 | 13/20 | 0.58 |
| ▸ | CASP4 | P49662 | 11/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.47 |
| ▸ | GBA1 | P04062 | 1/20 | 0.43 |
| ▸ | KMT5A | Q9NQR1 | 1/20 | 0.42 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.41 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9689152 | 1.00 | CASP1 (0.58) | CASP1CASP5CASP4MEN1CYP3A4 | |
| SCHEMBL9133699 | 1.00 | CASP1 (0.58) | CASP1CASP5CASP4MEN1CYP3A4 | |
| SCHEMBL9128566 | 1.00 | CASP1 (0.58) | CASP1CASP5CASP4MEN1CYP3A4 | |
| SCHEMBL9690413 | 1.00 | CASP1 (0.58) | CASP1CASP5CASP4MEN1CYP3A4 | |
| Hydrochloric Acid SCHEMBL9689522 | 0.99 | CASP1 (0.56) | CASP1CASP5CASP4MEN1CYP3A4 | |
| Hydrochloric Acid SCHEMBL9689155 | 0.99 | CASP1 (0.56) | CASP1CASP5CASP4MEN1CYP3A4 | |
| Hydrochloric Acid SCHEMBL9689562 | 0.99 | CASP1 (0.56) | CASP1CASP5CASP4MEN1CYP3A4 | |
| Hydrochloric Acid SCHEMBL9690251 | 0.99 | CASP1 (0.56) | CASP1CASP5CASP4MEN1CYP3A4 | |
| SCHEMBL9755198 | 0.94 | CASP1 (0.60) | CASP1CASP5CASP4MEN1CYP3A4 | |
| SCHEMBL9689057 | 0.91 | CASP1 (0.50) | CASP1CASP5CASP4MEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0358676-A1 | PHARMACEUTICALLY ACTIVE AMINES | THE UPJOHN COMPANY (US) | 1990-03-21 | — | — | EP | claimed |
| EP-0293078-A1 | Pharmaceutically active amines | THE UPJOHN COMPANY (US) | 1988-11-30 | — | — | EP | claimed |
| WO-1988008424-A1 | PHARMACEUTICALLY ACTIVE AMINES | THE UPJOHN COMPANY (US) | 1988-11-03 | — | — | WO | claimed |
| US-5120843-A | Nervous system disorders | UPJOHN (US) | 1992-06-09 | — | — | US | disclosed |
| EP-0487510-A1 | Pharmaceutically active amines | THE UPJOHN COMPANY (US) | 1992-05-27 | — | — | EP | disclosed |
| EP-0358676-A1 | PHARMACEUTICALLY ACTIVE AMINES | THE UPJOHN COMPANY (US) | 1990-03-21 | — | — | EP | disclosed |
| WO-1988008424-A1 | PHARMACEUTICALLY ACTIVE AMINES | THE UPJOHN COMPANY (US) | 1988-11-03 | — | — | WO | disclosed |